latest news releases from the newsroom
Turnaround Partners, Inc.
Hecla Mining CEO Phil Baker to Appear on `Corporate Strategies with Tim Connolly' Sunday, January 29, 2006 at 9:00 pm EST
HOUSTON, Jan. 27, 2006 (PRIMEZONE) -- Hecla Mining (NYSE:HL) (Hecla Mining) CEO Phil Baker to appear Sunday, January 29, 2006 at 9:00 pm EST on "Corporate Strategies with Tim Connolly". Mr. Baker will be discussing the price of silver at its highest since 1984. Additionally Powder River Basin Gas Corp (OTCBB:PRVB) CEO Brian Fox will also appear on "Corporate Strategies with Tim Connolly". Previous guests of the show have included U.S. Senator John McCain, ChangeWave Research's Bryan Perry, Enterprise Products CEO Dan Duncan, Celgene's CEO John Jackson, Landry's CEO Tilman Fertitta, Mario Gabelli, former SEC Chairman Arthur Levitt, former Compaq CEO Eckard Pfeiffer, Money Manager Louis Navellier, and many others. Emerge Capital Corp. (OTCBB:EMGC) is the lead sponsor of The Corporate Strategies Business Talk Radio Show which may be heard on KSEV AM 700 in Houston, Texas, WGCH AM 1490 in Greenwich, Connecticut, WSBR AM 740 in Boca Raton, Florida, and on over 400 affiliate stations nationwide listed at CRN1 www.cableradionetwork.com, or on the Internet at www.businesstalkradio.net. This hour of "Corporate Strategies with Tim Connolly" is hosted by Tim Connolly of Corporate Strategies Merchant Bankers (www.corporate-strategies.net). Noted Economist Mike King of Princeton Research provides live technical analysis for the show.
Parker Waichman Alonso LLP
Parker & Waichman, LLP Continues to Investigate Hundreds of Claims of Ortho Evra Related Injuries; Firm Files New Case Against Ortho-McNeil Pharmaceutical, Inc. on Behalf of Ortho Evra Victim Who Suffered Pulmonary Emboli at Age 31 -- JNJ
NEW YORK, Jan. 27, 2006 (PRIMEZONE) -- Parker & Waichman, LLP (http://www.yourlawyer.com) announced that it has filed suit against Ortho-McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc. (NYSE:JNJ), on behalf of a woman who suffered bilateral pulmonary emboli in December 2003 at the age of 31 after using the Ortho Evra contraceptive patch for 15 days. The plaintiff began using the patch on December 15, 2003, and subsequently began experiencing severe chest pain and shortness of breath. On December 30, 2003, after her symptoms worsened, the plaintiff was taken to the emergency room. Diagnostic tests at the hospital revealed bilateral pulmonary emboli, and the plaintiff was admitted to the hospital for Heparin and Coumadin (anticoagulant) therapy. The plaintiff has undergone prolonged treatment with these medications, and the treatment may be necessary for the remainder of her life. The suit was filed in the United States District Court for the District of New Jersey in Newark, New Jersey. For more information on Ortho Evra please visit http://www.orthopatchlawsuit.com or http://www.yourlawyer.com/topics/overview/Ortho_Evra_Patch.
Nuclear Solutions, Inc.
Future Fuels, Inc. Reports Progress Toward Operations and Technology for Waste-To-Ethanol Production Facility
WASHINGTON, D.C., Jan. 27, 2006 (PRIMEZONE) -- Future Fuels, Inc. (FFI), a subsidiary of Nuclear Solutions, Inc. (OTCBB:NSOL), announced today that it has retained Regulatory Compliance Consulting, LLC (RCC), headed by Jack McCrossin, to direct a competitive bidding process aimed at selecting an operator to manage and maintain operations at its first waste-to-ethanol production facility to be constructed in Toms River, New Jersey.
Morris, Manning & Martin, LLP
Likely Enron Defense Strategy Unconventional, Risky and Fascinating, Former Prosecutor and SEC Enforcement Attorney Says
ATLANTA, Jan. 27, 2006 (PRIMEZONE) -- Published reports indicate that attorneys for Enron founder and former Chairman and CEO, Kenneth Lay, and former CEO and President, Jeffrey Skilling, will try to convince a jury that the financial maneuverings that led to Enron's collapse were, in fact, legitimate business practices, which were perfectly legal. A securities litigator who worked at both the U.S. Department of Justice and the U.S. Securities and Exchange Commission says this tactic could well prove to be both risky and fascinating.